The significantly higher clusterin concentrations in PsA patients in comparison to the RA group, in our opinion, is an especially important observation because each additional parameter enabling the differentiation of PsA and RA is very valuable from the diagnostic and clinical point of view as well. This evidence concerns the gene CLU and rheumatoid arthritis.